Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study
Authors:
- Laura Martin-PiedraLMLaura Martin-Piedra
- Juan F. Alcala-DiazJAJuan F. Alcala-Diaz
- Francisco M. Gutierrez-MariscalFGFrancisco M. Gutierrez-Mariscal
- Antonio P. Arenas de LarrivaALAntonio P. Arenas de Larriva
- Juan L. Romero-CabreraJRJuan L. Romero-Cabrera
- Jose D. Torres-PeñaJTJose D. Torres-Peña
- Javier Caballero-VillarrasoJCJavier Caballero-Villarraso
- Raul M. LuqueRaul M. Luque
- Pablo Perez-MartinezPPPablo Perez-Martinez
- Jose Lopez-MirandaJLJose Lopez-Miranda
- Javier Delgado-ListaJDJavier Delgado-Lista
Open Access
- 12 November 2021
- Vol. 13 (11) , 4046
Abstract
Background: Obesity phenotypes with different metabolic status have been described previously. We analyzed metabolic phenotypes in obese coronary patients during a 5-year follow-up, and examined the factors influencing this evolution. Methods: The CORDIOPREV study is a randomized, long-term secondary prevention study with two healthy diets: Mediterranean and low-fat. All obese patients were classified as either metabolically healthy obese (MHO) or metabolically unhealthy obese (MUO). We evaluated the changes in the metabolic phenotypes and related variables after 5 years of dietary intervention. Results: Initially, 562 out of the 1002 CORDIOPREV patients were obese. After 5 years, 476 obese patients maintained their clinical and dietary visits; 71.8% of MHO patients changed to unhealthy phenotypes (MHO-Progressors), whereas the MHO patients who maintained healthy phenotypes (MHO-Non-Progressors) lost more in terms of their body mass index (BMI) and had a lower fatty liver index (FLI-score) (p < 0.05). Most of the MUO (92%) patients maintained unhealthy phenotypes (MUO-Non-Responders), but 8% became metabolically healthy (MUO-Responders) after a significant decrease in their BMI and FLI-score, with improvement in all metabolic criteria. No differences were found among dietary groups. Conclusions: A greater loss of weight and liver fat is associated with a lower progression of the MHO phenotype to unhealthy phenotypes. Likewise, a marked improvement in these parameters is associated with regression from MUO to healthy phenotypes.Keywords
Funding Information
- Fundación Patrimonio Comunal Olivarero (CORDIOPREV-CEAS, 1/2016)
- Ministerio de Ciencia e Innovación.Spain (AGL2012-39615, AGL2015-67896-P, PID2019-104362RB-I00)
- Spanish Government of Investigation, Development and Innovation (SAF2017-84135-R)
This publication has 47 references indexed in Scilit:
- Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish populationEuropean Journal of Nutrition, 2013
- Body Size Phenotypes and Inflammation in the Women's Health Initiative Observational StudyObesity, 2011
- Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik StudyObesity, 2011
- Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic SyndromeObesity, 2010
- Downregulation of Adipose Tissue Fatty Acid Trafficking in ObesityDiabetes, 2010
- Insulin-sensitive obesityAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor ClusteringArchives of internal medicine (1960), 2008
- The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistancePhysiology & Behavior, 2008
- Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose MetabolismDiabetes Care, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003